As of 2024-09-13, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is (7.46) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.49 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -1637.9%.
The range of the Relative Valuation is (6.44) - (8.24) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.6x - 2.5x | 2.0x |
| Forward P/E multiples | 1.4x - 2.1x | 1.8x |
| Fair Price | (6.44) - (8.24) | (7.46) |
| Upside | -1427.5% - -1799.8% | -1637.9% |
| Date | P/E |
| 2024-09-12 | -0.12 |
| 2024-09-11 | -0.12 |
| 2024-09-10 | -0.13 |
| 2024-09-09 | -0.12 |
| 2024-09-06 | -0.13 |
| 2024-09-05 | -0.13 |
| 2024-09-04 | -0.13 |
| 2024-09-03 | -0.14 |
| 2024-08-30 | -0.14 |
| 2024-08-29 | -0.14 |
| 2024-08-28 | -0.14 |
| 2024-08-27 | -0.14 |
| 2024-08-26 | -0.14 |
| 2024-08-23 | -0.14 |
| 2024-08-22 | -0.14 |
| 2024-08-21 | -0.17 |
| 2024-08-20 | -0.17 |
| 2024-08-19 | -0.16 |
| 2024-08-16 | -0.15 |
| 2024-08-15 | -0.18 |
| 2024-08-14 | -0.17 |
| 2024-08-13 | -0.17 |
| 2024-08-12 | -0.17 |
| 2024-08-09 | -0.18 |
| 2024-08-08 | -0.20 |
| 2024-08-07 | -0.17 |
| 2024-08-06 | -0.17 |
| 2024-08-02 | -0.17 |
| 2024-08-01 | -0.19 |
| 2024-07-31 | -0.20 |
| 2024-07-30 | -0.20 |
| 2024-07-29 | -0.19 |
| 2024-07-26 | -0.20 |
| 2024-07-25 | -0.20 |
| 2024-07-24 | -0.21 |
| 2024-07-23 | -0.22 |
| 2024-07-22 | -0.23 |
| 2024-07-19 | -0.23 |
| 2024-07-18 | -0.22 |
| 2024-07-17 | -0.23 |
| 2024-07-16 | -0.24 |
| 2024-07-15 | -0.25 |
| 2024-07-12 | -0.24 |
| 2024-07-11 | -0.25 |
| 2024-07-10 | -0.26 |
| 2024-07-09 | -0.25 |
| 2024-07-08 | -0.26 |
| 2024-07-05 | -0.26 |
| 2024-07-04 | -0.28 |
| 2024-07-03 | -0.25 |